Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate Dose-Volume Study in Glaucoma
NCT00788541Phase 2Terminated
- Sponsor
- Alcon Inc.
- Start
- Dec 2008
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anecortave in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Dec 2008; status: terminated.
02
Drugs
anecortave
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00788541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00788541.